The Genom of Homo sapiens.pdf

GENETICS OF COMMON DISEASES 401F., Twells R.C., Payne F., Hughes W., Nutland S., Stevens H.,Carr P., Tuomilehto-Wolf E., Tuomilehto J., Gough S.C.,Clayton D.G., and Todd J.A. 2001. Haplotype tagging for theidentification of common disease genes. Nat. Genet. 29: 233.Judson R., Salisbury B., Schneider J., Windemuth A., andStephens J.C. 2002. How many SNPs does genome-wide haplotypemap require? Pharmacogenomics 3: 379.Ke X., Hunt S., Tapper W., Lawrence R., Stavrides G., Ghori J.,Whittaker P., Collins A., Morris A.P., Bentley D., CardonL.R., and Deloukas P. 2004. The impact of SNP density onfine-scale patterns of linkage disequilibrium. Hum. Mol.Genet. (in press).Kruglyak L. 1999. Prospects for whole-genome linkage disequilibriummapping of common disease genes. Nat. Genet. 22:139.Kruglyak L. and Nickerson D.A. 2001. Variation is the spice oflife. Nat. Genet. 27: 234.Lohmueller K.E., Pearce C.L., Pike M., Lander E.S., andHirschhorn J.N. 2003. Meta-analysis of genetic associationstudies supports a contribution of common variants to susceptibilityto common disease. Nat. Genet. 33: 177.McCarthy M.I. 2004. Progress in defining the molecular basis oftype 2 diabetes mellitus through susceptibility-gene identification.Hum. Mol. Genet. (in press).Pastor P., Roe C.M., Villegas A., Bedoya G., Chakraverty S.,Garcia G., Tirado V., Norton J., Rios S., Martinez M., KosikK.S., Lopera F., and Goate A.M. 2003. Apolipoprotein Eepsilon4modifies Alzheimer’s disease onset in an E280A PS1kindred. Ann. Neurol. 54: 163.Pritchard J.K. and Przeworski M. 2001. Linkage disequilibriumin humans: Models and data. Am. J. Hum. Genet. 69: 1.Reich D.E., Cargill M., Bolk S., Ireland J., Sabeti P.C., RichterD.J., Lavery T., Kouyoumjian R., Farhadian S.F., Ward R.,and Lander E.S. 2001. Linkage disequilibrium in the humangenome. Nature 411: 199.Riordan J.R., Rommens J.M., Kerem B., Alon N., Rozmahel R.,Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J.L., et al.1989. Identification of the cystic fibrosis gene: Cloning andcharacterization of complementary DNA. Science 245: 1066.Risch N. and Merikangas K. 1996. The future of genetic studiesof complex human diseases. Science 273: 1516.Sebastiani P., Lazarus R., Weiss S.T., Kunkel L.M., Kohane I.S.,and Ramoni M.F. 2003. Minimal haplotype tagging. Proc.Natl. Acad. Sci. 100: 9900.Siddiqui A., Kerb R., Weale M.E., Brinkmann U., Smith A.,Goldstein D.B., Wood N.W., and Sisodiya S.M. 2003. Associationof multidrug resistance in epilepsy with a polymorphismin the drug-transporter gene ABCB1. N. Engl. J. Med.348: 1442.Stram D.O., Haiman C.A., Hirschhorn J.N., Altshuler D.,Kolonel L.N., Henderson B.E., and Pike M.C. 2003. Choosinghaplotype-tagging SNPS based on unphased genotype data usinga preliminary sample of unrelated subjects with an examplefrom the Multiethnic Cohort Study. Hum. Hered. 55: 27.Weale M.E., Depondt C., Macdonald S.J., Smith A., Lai P.S.,Shorvon S.D., Wood N.W., and Goldstein D.B. 2003. Selectionand evaluation of tagging SNPs in the neuronal-sodiumchannelgene SCN1A: Implications for linkage-disequilibriumgene mapping. Am. J. Hum. Genet. 73: 551.Weedon M.N., Schwarz P.E., Horikawa Y., Iwasaki N., Illig T.,Holle R., Rathmann W., Selisko T., Schulze J., Owen K.R.,Evans J., Del Bosque-Plata L., Hitman G., Walker M., LevyJ.C., Sampson M., Bell G.I., McCarthy M.I., Hattersley A.T.,and Frayling T.M. 2003. Meta-analysis and a large associationstudy confirm a role for calpain-10 variation in type 2 diabetessusceptibility. Am. J. Hum. Genet. 73: 1208.Wright A.F. and Hastie N.D. 2001. Complex genetic diseases:Controversy over the Croesus code. Genome Biol. 2: COM-MENT2007.Zondervan K.T. and Cardon L.R. 2004. The complex interplayamong factors that influence allelic association. Nat. Rev.Genet. 5: 89.